Friday 6 November 2026 Export LGVN’s income statement to Excel — free account

Longeveron Inc.

LGVN Healthcare Biotechnology

Longeveron Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 million, down 49.9% from fiscal 2024.

Revenue: −9.18%
EPS: +42.4%
Free cash flow: −49.1%

Quarter to June 2026, against a year earlier

1.79 0.08 +4.68%

Follow LGVN

Alert me

Market cap: $5.5M
P/E: 0.0×
Fwd P/E: −0.2×
Dividend yield: —
F-score: 3/9
Altman Z: −24.10
Beneish M: −3.83
Dividend safety: n/a

Overview

	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25
P/E ratio Full definition →	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Piotroski F-Score Full definition →	—	—	—	5	3	3	2	5	3
P/S ratio Full definition →	—	21.09	21.09	21.09	174.86	57.83	40.46	10.84	7.42
Altman Z-Score Full definition →	—	—	—	—	23.95	1.20	(12.02)	(4.58)	(24.10)
Altman Z″-Score (non-manufacturers) Full definition →	—	—	—	(13.36)	6.32	(5.08)	(32.25)	(7.69)	(55.12)
P/FCF ratio Full definition →	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Beneish M-Score Full definition →	—	—	—	(3.16)	(7.22)	(0.45)	(3.82)	(1.65)	(3.83)
P/Operating CF Full definition →	—	(235.07)	(235.07)	(235.07)	(178.27)	(30.62)	(7.18)	(7.69)	(1.68)
P/B ratio Full definition →	—	60.66	60.66	60.66	6.10	3.45	4.26	1.19	1.57
Price to Tangible BV Full definition →	—	289.53	289.53	289.53	6.50	3.91	6.44	1.33	2.62
EV/Sales Full definition →	—	21.02	21.02	21.02	150.02	43.42	34.94	3.15	3.68
EV/EBITDA Full definition →	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	—	(50.06)	(50.06)	(50.06)	(20.33)	(3.80)	(1.30)	(0.54)	(0.24)
EV/FCF Full definition →	—	(45.07)	(45.07)	(45.07)	(17.95)	(3.58)	(1.26)	(0.51)	(0.23)
Quick Ratio Full definition →	—	2.16	0.93	0.32	12.96	4.08	1.41	7.48	1.17
Current Ratio Full definition →	—	2.24	0.95	0.48	13.07	4.17	1.50	7.60	1.33
Net Debt/EBITDA Full definition →	—	0.72	(1.02)	0.12	1.96	1.03	0.19	1.18	0.20
Debt/Assets Full definition →	0.00%	0.00%	39.10%	4.87%	6.09%	7.45%	11.99%	3.22%	1.65%
Debt/Equity Full definition →	—	0.00	0.93	0.23	0.07	0.10	0.21	0.04	0.03
Asset Turnover Full definition →	—	0.41	0.53	0.57	0.05	0.03	0.04	0.13	0.07
Operating CF/Net income Full definition →	—	0.82	0.81	0.64	0.57	0.74	0.86	0.56	0.82
Capex/Depreciation Full definition →	—	0.00	(0.16)	(0.33)	(1.34)	(0.96)	(0.73)	(1.04)	(0.49)
Interest Coverage Full definition →	—	(534.50)	(14,990.50)	(539.71)	4,364.00	—	—	—	—
ROE Full definition →	—	(112.56%)	(52.58%)	(116.24%)	(86.50%)	(65.00%)	(163.05%)	(172.02%)	(164.75%)
ROA Full definition →	—	(120.45%)	(28.05%)	(37.54%)	(65.55%)	(53.68%)	(112.49%)	(130.85%)	(126.77%)
ROIC Full definition →	—	0.00%	(27.89%)	(148.41%)	(217.55%)	(390.74%)	(464.75%)	(296.82%)	(1,230.29%)
Return on Tangible Assets Full definition →	—	(89.73%)	(72.68%)	(230.26%)	(47.70%)	(102.59%)	(494.90%)	(126.33%)	(709.50%)
Average Days of Receivables Full definition →	—	0.00	29.22	27.23	15.37	65.11	57.14	12.82	31.66
Research and Development Expense of Revenue Full definition →	—	181.55%	31.77%	47.50%	543.03%	766.78%	1,278.70%	340.18%	1,004.25%
Selling, General and Administrative Expense of Revenue Full definition →	—	148.28%	52.49%	52.05%	838.74%	750.41%	1,718.48%	429.31%	1,004.92%
Intangible Assets out of Total Assets Full definition →	0.00	0.13	0.14	0.17	0.05	0.09	0.19	0.09	0.22
Share Based Compensation of Revenue Full definition →	—	0.00%	2.43%	0.69%	493.34%	177.33%	286.60%	97.32%	139.87%
Graham Net Nets Full definition →	—	(0.05)	(0.05)	(0.05)	0.13	0.19	0.02	0.62	0.10
Graham Number Full definition →	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	—	(3.14%)	(3.14%)	(3.14%)	(7.37%)	(26.71%)	(77.27%)	(234.23%)	(258.45%)
Free Cash Flow Yield Full definition →	—	(2.21%)	(2.21%)	(2.21%)	(4.78%)	(20.98%)	(68.67%)	(57.29%)	(216.33%)
Revenue per Share Full definition →	—	0.11	0.30	35.14	6.90	5.83	3.26	2.54	0.68
Operating CF per Share Full definition →	—	(0.27)	(0.13)	(14.76)	(50.93)	(66.61)	(87.43)	(14.74)	(10.61)
Capex per Share Full definition →	—	0.00	(0.01)	(1.63)	(6.47)	(4.08)	(3.19)	(1.05)	(0.34)
Free Cash Flow per Share Full definition →	—	(0.27)	(0.13)	(16.39)	(57.40)	(70.70)	(90.62)	(15.79)	(10.95)
Cash per Share Full definition →	—	0.21	0.10	5.09	185.22	93.74	24.67	20.44	2.65
Shareholders Equity per Share Full definition →	—	0.36	0.23	12.22	197.95	97.77	31.01	23.26	3.23
Interest Debt per Share Full definition →	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book value per Share Full definition →	—	0.36	0.23	12.22	197.95	97.77	31.01	23.26	3.23
Free Cash Flow Full definition →	—	(5.18)	(2.52)	(2.62)	(10.86)	(14.82)	(19.70)	(14.86)	(19.24)
Working Capital Full definition →	—	2.30	(0.12)	(1.98)	32.67	15.41	1.96	17.04	1.36
Capital Expenditures Full definition →	—	(0.21)	(0.13)	(0.26)	(1.22)	(0.86)	(0.69)	(0.99)	(0.59)
Net Current Asset Value Full definition →	—	0.46	(3.77)	(5.43)	30.07	13.37	0.51	15.95	0.87
EV/EBIT Full definition →	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	—	0.00	0.02	0.05	0.94	0.70	0.98	0.41	0.50
Price to Operating Income Full definition →	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other line items
Depreciation/Fixed assets Full definition →	—	0.16	0.18	0.22	0.30	0.30	0.37	0.39	0.67
Cash ROIC Full definition →	—	(47.74%)	(24.08%)	(81.45%)	(14.46%)	(35.13%)	(145.36%)	(35.43%)	(183.15%)
Accounts Receivable Turnover Full definition →	—	0.00	12.93	12.92	5.50	8.95	4.31	24.53	12.76
Accounts Payable Turnover Full definition →	—	1.23	3.29	2.77	0.64	0.61	0.41	1.38	1.52
Inventory Turnover Full definition →	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	—	302.57	108.47	152.60	328.81	881.54	477.19	71.13	389.89
Days of Inventory on Hand Full definition →	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Average Receivables Full definition →	—	—	0.44	0.44	0.24	0.14	0.16	0.10	0.09
Average Payables Full definition →	—	1.18	1.18	1.37	1.12	1.20	1.19	0.37	0.26
Average Assets Full definition →	—	5.26	10.55	9.91	26.00	35.09	19.75	18.82	17.91
Average Common Equity Full definition →	—	5.63	5.63	3.20	19.71	28.98	13.62	14.31	13.78

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026

Stockrow Weekly